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evier B.VAbstract Aim of the Work: Evaluate the role of MRI in diagnosing hip arthritis and correlating it
with clinical and laboratory assessment in juvenile idiopathic arthritis (JIA).
Patients and Methods: Study included 30 patients with JIA with mean age 13.5 ± 4.5. Disease
activity was evaluated by DAS28 score, physician’s global assessment (PGA–VAS), patient’s global
assessment (VASglobal) and assessment of functional ability by (CHAQ). Hip joint evaluation was
assessed by hip pain on movement and degree of limitation of motion (score 0–3). Plain radiogra-
phy and MRI of hip joint were performed for all patients. MRI score was done.
Results: MRI of hips was abnormal in 12 (40%) of all patients: 2/8 (25%) of oligoarticular
group, 4/13 (30.8%) of polyarticular group, 5/7 (71.4%) of systemic onset group and 1/2(50%)
of enthesitis related group. Comparing mean values of MR score of the four clinical subsets showed
signiﬁcant difference (p< 0.001). Patients with active disease showed higher MR score (3.7 ± 1.5)
than those with inactive disease (2.1 ± .9) [p< 0.002]. Presence of effusion and gadolinium
enhancement were signiﬁcantly higher in active hips (p< 0.01 and p< 0.001 respectively). VAS–
PGA and ESR were signiﬁcantly correlated with MRI score (p< 0.02 and <0.05 respectively).geesh street, Medan El Saa,
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76 M.I.A. El-Azeem et al.Conclusion: MRI of the hip plays an important role in the study of patients with JIA as it reveals
early joint involvement and evaluates the extent of joint disease. This permits intervention at an
appropriate time with suitable treatment. Clinical and laboratory ﬁndings are inadequate diagnostic
tools for the assessment of hip arthritis comparing with MRI.
 2012 Egyptian Society for Joint Diseases and Arthritis. Production and hosting by Elsevier B.V.
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Juvenile idiopathic arthritis (JIA) is a chronic multisystem
inﬂammatory disease with prominent joint manifestation [1].
It is the most common form of childhood arthritis [2]. It is char-
acterized by joint inﬂammation with onset at or before 16 years
of age [3]. Hip involvement in juvenile idiopathic arthritis (JIA)
is common [4] and is a cause of signiﬁcant functional impair-
ment [5]. Hip joint involvement occurs in 35–63% of JIA pa-
tients and its late detection may be the cause of serious
disability [6]. Long-term follow-up shows that total hip replace-
ments are carried out in 26–44% of JIA patients, most com-
monly within the ﬁrst 10 years of disease [7]. The development
of hip arthritis is likely to be an indication for treatment with
disease modifying and biological agents [8]. Unfortunately,
the clinical detection of hip arthritis is difﬁcult as inﬂamed syn-
ovium cannot be directly palpated. As a result, subclinical hip
arthritis can lead to joint damage [9]. Clinical parameters in
the early stages of the disease have been shown to be very useful
for predicting the articular outcome of JIA [10]. Radiographic
changes mostly represent late and indirect signs [11]. In addi-
tion, early detection of joint involvement would allow interven-
tion at the appropriate time [12]. Based on these facts and on the
limitation of plain radiographs for detecting radiological
changes, there is a real need for other radiological variables to
assess the joints in patients with arthritis [13].
The use of MRI in the assessment of the musculoskeletal
system in children has important differences from its use in
adults. Growth in children has signiﬁcant impact on the epiph-
ysis and growth plate, and there are radiological features that
differ from those in adults; MRI is a sensitive and valuable
imaging technique in pediatric musculoskeletal pathologies,
with considerable potential for future developments to en-
hance its role in diagnosis, management, and therapeutic inter-
vention [14,15]. Magnetic resonance imaging allows the
visualization of bone and soft tissues in three dimensions using
a multiplanar technique. Bony erosions are seen well using
MRI in early rheumatoid arthritis (RA) and are frequently de-
tected before they appear on plain radiographs. Bone marrow
edema is another important MRI feature associated with
inﬂammatory joint disease and may be a forerunner of erosion.
MRI after intravenous administration of gadolinium diethyl-
enetriamine pentaacetic acid (Gd-DTPA) has become an
established tool for demonstrating inﬂammatory synovial pro-
liferation in RA [16]. Joint effusions may be distinguished from
synovium using gadolinium enhancement because they appear
as areas of low signal intensity on T1-weighted images. Fol-
lowing gadolinium injection, the highly vascular inﬂamed syn-
ovium enhances brightly while joint effusion remains of low
signal [16]. Bony erosions appear as focal defects within corti-
cal bone where the normal signal intensity is reduced on T1
and increased on T2 weighted images. Erosions often enhanceafter intravenous injection of GD-DTPA, implying the
presence of inﬂamed synovium within the defect [17]. Bone
marrow oedema appears as increased signal intensity of bone
on T2-weighted images after fat suppression, resulting from
an increased amount of water in the marrow. Bone marrow oe-
dema in early RA has been found to be strongly associated
with subsequent erosion at the same site and appears an
important early pathological feature [18].
In our study, we aimed to correlate clinical activity and lab-
oratory assessment of hip joint disease with MRI as the gold
standard method for detecting hip joint disease in JIA.
2. Patients and methods
Thirty patients with JIA were included in the study. They were
recruited from Rheumatology and Rehabilitation and Internal
Medicine Departments, Beni Suef and Minia university hospi-
tals between April, 2009 and February, 2011. They were diag-
nosed and classiﬁed according to International League of
associations for Rheumatology Classiﬁcation of juvenile idio-
pathic arthritis (ILAR) [19].
Informed consent was obtained from the parents of all chil-
dren. The study was performed with the approval of local eth-
ics committee.
Laboratory investigations included hemoglobin concentra-
tion, erythrocyte sedimentation rate (ESR), quantitative C-
reactive protein (CRP), rheumatoid factor (RF) [20], and anti-
nuclear antibodies (ANAs) by immunoﬂuorescence [21].
Clinical assessment of disease activity was performed using
the modiﬁed disease activity score of 28 joint count (DAS 28)
[22]. DAS is a statistically derived index consisting of number
of tender joints, number of swollen joints, erythrocyte sedi-
mentation rate, and patient’s global assessment of disease
activity (VAS-global). Physician’s global assessment (PGA–
VAS) and VAS-global were evaluated using 100 mm visual
analogue scale (0 = no activity and 100 mm=maximum
activity). Assessment of functional ability, using the childhood
health assessment questionnaire (CHAQ), (CHAQ; 0 = best
and 3 = worst) [23] was also performed. Evaluation of hip
joint was assessed according to Frosch et al. [24] including
hip joint pain on movement, score 0–3 (0 = none; 1 = mild,
patient complains on movement; 2 = moderate, patient with-
draws or changes facial expression on movement; 3 = severe,
patients responds severely to movement) and the degree of lim-
itation of motion, score 0–3 (0 = normal joint mobility;
1 =<10; 2 = 10–30; 3 => 30 reduction from normal
joint mobility). Patients with a mean total scoreP1 were clas-
siﬁed as having active hip involvement, while patients with
normal physical ﬁndings were considered to be inactive.
MRI examinations were performed on both hip joints on
1.0 Tesla system (Intera, Philips Medical Systems, Best, The
Netherlands) using a body coil. Both hips were examined
Table 1 Demographic, disease activity indices, and laboratory
characteristics of the study group.
Patient’s group no. = 30
Age (y) 13.5 ± 4.5 (6.5–19.8)
Mean ± SD (range)
Sex (males/females) (12/18) (40%/60%)
Disease duration (y)
Mean ± SD (range) 6.5 ± 3.5(1–12) years
DAS 28
Mean ± SD (range) 4.2 ± 1.1 (1.2–5.6)
VAS-global
Mean ± SD (range) 38 ± 11 (8–74)
VAS–PGA mm
Mean ± SD (range) 23 ± 22 (10–57)
CHAQ score
Mean ± SD (range) 1.1 ± 0.74 (0.5–2.1)
Presence of hip pain no (%) 7 (23.3%)
Limitation of motion no (%) 5 (16.7%)
Clinical hip score
Mean ± SD (range) 2.1 ± 2 (0–4.5)
Hemoglobin g/dl
Mean ± SD (range) 11.2 ± 1.5 (8.5–13.1)
ESR mm/h
Mean ± SD (range) 45.1 ± 20.5 (10–77)
CRP (mg/dl)
Mean ± SD (range) 27.4 ± 18.9 (5–33)
RF no(%): +ve 9 (30%)
ve 21 (70%)
ANA no(%): +ve 2 (6.7%)
ve 28 (93.3%)
y = years, DAS28 = disease activity score 28, VAS Global = vi-
sual analogue scale, VAS–PGA= visual analogue scale–physician
global assessment, CHAQ score = childhood health assessment
questionnaire, ESR= erythrocyte sedimentation rate, CRP = C-
reactive protein, RF = rheumatoid factor, ANA= antinuclear
antibody. Data are given as number (%) or mean ± SD (range).
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quences including:
 T1 weighted sequence (TR = 400–600 ms, TE = 9–18 ms).
 T2 weighted sequence (TR = 3000–4000 ms, TE =100 ms).
 STIR (short time inversion recovery) sequence with inver-
sion time T1 two to three times the echo time.
 Gradient echo sequence with 15 ﬂip angle (TR = 440 ms,
TE = 12 ms).
 Post-contrast MR images were obtained for all patients after
I.V. injection of 0.1 mmol/kg of Gd-DTPA (gadolinium
diethylene Triamine Penta acetic acid) (Magnevist; Schering,
Berlin, Germany) with the following MRI sequences; coro-
nal T1, T2 and STIR images, axial T1, sagittal T2 images
and coronal gradient echo images [ﬁeld of view (24–30 cm),
slice thickness (7-mm) and inter-slice gap (3–4 mm)].
 The degree of joint ﬂuid was graded as described by Mitch-
ell et al. [25] , grade 0, no sign of effusion; grade 1, trace of
effusion; grade 2, continual effusion; grade 3, effusion with
distension of the capsule. Hydrops was deﬁned as joint ﬂuid
Pgrade 2.
 The synovial thickness was measured as the observed max-
imum thickness of the synovium (P2) in any part of the
joint. The degree of bone marrow edema was graded as
none, 61/3 involvement of the epi-, meta- or diaphysis.
The degree of soft tissue edema was graded as none, trace
or marked.
MRI grading score was done as follows: Hips were scored for
signs of active synovitis with 1 point each for joint effusion,
gadolinium-enhancing synovium P2 mm, and soft tissue ede-
ma. Damage was scored with 1 point each for bony erosions,
cartilage loss, bony remodeling and acetabular protrusion.
MRI images were considered to be abnormal if the respective
activity and damage scores were >0 [26].
Statistical analysis: Data were collected, coded and ana-
lyzed using SPSS version 13 software under windows xp.
Descriptive Analysis of the results was done in the form of per-
centage distribution for qualitative data, mean and standard
deviation calculation for quantitative data. It was followed
by applying the suitable tests of signiﬁcance. Analysis of vari-
ance (ANOVA) was used to compare MRI grading score of
the clinical subtypes followed by the least signiﬁcant difference
(LSD) test. Student’s t test was used to compare quantitative
variables, Chi square and Fisher exact test were used to com-
pare qualitative variables. Multiple regression analysis was
used to correlate the MRI score with clinical and laboratory
variables. When correlating lateralizing variables such as clini-
cian’s assessment with MRI scores, the hip joints of each indi-
vidual were considered to be independent. Non-lateralizing
variables such as disease duration, and ESR were correlated
with the patient’s combined hip scores. P< 0.05 was deﬁned
as being statistically signiﬁcant.3. Results
The study population included 12 males and 18 females, their
mean age was (13.5 ± 4.5), ranging from 6.5 to 19.8 years old.
The mean duration of disease was 6.5 ± 3.5 ranging from 1 to
12 years. Eight patients (26.7%) had oligoarthritis, 13 (43.3%)
had polyarthritis, 2 (6.7%) had enthesitis related and 7(23.3%) had systemic onset arthritis. Table 1 shows their
demographic, clinical and laboratory characteristics. Eighteen
patients (26.7%) were receiving methotrexate, 8 (26.7%)
Leﬂunomide, 4 (13.3%) combined methotrexate and leﬂuno-
mide, 11 (36.7%) Hyroxychloroquine and 5 (16.7%) oral
prednisolone.
3.1. MRI ﬁndings
MRI examination of hip joints was abnormal in 12/30 (40%)
of patients: 2/8 (25%) of oligoarticular group, 4/13 (30.8%)
of polyarticular group, 5/7 (71.4%) of systemic onset group
and 1/2(50%) of enthesitis related group.
ANOVA between the four clinical subsets showed a signiﬁ-
cant difference between the mean values of the MR score
(p< 0.001). The LSD test showed a signiﬁcant difference
between oligoarthritis and polyarthritis group (p< 0.01), how-
ever no signiﬁcant difference was present between polyarthritis
and systemic group (p< 0.2). Table 2.
3.2. MRI ﬁndings and clinical assessment
By MRI, joint effusion was present in 10 (55.6%) of clinically
active hips, 5 (27.8%) of them have grade 3 effusion. Only 3
(7.1%) of the clinically inactive hips have joint effusion, 2
Table 2 MRI results of the study group.
Oligoarthritis no. = 8 Enthesitis related no. = 2 Polyarthritis no. = 13 Systemic onset no. = 7
Abnormal/total 2/8 ½ 4/13 5/7
MRI score (mean ± SD) 2.8 ± 1.5 2.9 ± 1.1 3.6 ± 1.8 3.8 ± 1.6
Signiﬁcance P< 0.001\
Table 3 MRI score and characteristics according to clinical activity of hip arthritis.
Clinical assessment P
Active no:18 Inactive no:42
Total MR score 3.7 ± 1.5 2.1 ± .9 0.002\
Eﬀusion no (%) 10 (55.6%) 3 (7.1%) 0.01\
Grade 1 2 (11.1%) 1 (2.4%)
Grade 2 3 (16.7%) 2 (4.8%)
Grade 3 5 (27.8%) 0
Gad enhancing synovium >2 mm no (%) 15 (83.3%) 2 (4.8%) 0.001\
Maximal synovial thickness (mm) mean ± SD 3.56 ± 1.81 2.91 ± 1.1 0.08
Any soft tissue edema no (%) 3 (16.7%) 0 (0%) 0.8
Any bone marrow edema no (%) 2 (11.1%) 0 (0%) 0.5
Erosions no (%) 2 (11.1%) 2 (4.8%) 0.9
Cartilage loss no (%) 5 (27.8%) 2 (4.8%) 0.1
Bone remodeling no (%) 1 (5.6%) 0 (0%) 0.9
Acetabular protrusion no (%) 1 (5.6%) 0 (0%) 0.9
Data are given as number (%) or mean ± SD.
78 M.I.A. El-Azeem et al.(4.8%) have grade 3 effusion. Gadolinium enhancing synovium
was far more prevalent in clinically active hips (86.3%) than
inactive ones (4.8%). Presence of effusion and Gadolinium
enhancement were signiﬁcantly higher in active hips
(p< 0.01 and p< 0.001 respectively). Maximal synovial thick-Figure 1 Coronal T2 weighted MR image of the hip joints in a
12-year-old child with JIA showing bilateral bright signal intensity
within the joint space (arrows) which may represent synovial
thickening or joint effusion. Focal bright signal is seen at the right
femoral head due to bone erosion.ness was higher in clinically active hips (3.56 ± 1.81) than
inactive ones (2.91 ± 1.1), but this does not reach statistical
signiﬁcance. Soft tissue edema and bone marrow edema were
present in 16.7% and 11.1% respectively of clinically active
hips and not present in inactive hips.Figure 2 Coronal fat saturated T1 weighted MR image after
gadolinium injection in the same patient in Fig. 1 showing diffuse
synovial enhancement >2 mm (arrows) denoting active synovitis.
Bone erosion is again seen as bright signal at the right femoral
head under the inﬂamed synovium.
Figure 3 Coronal T2 weighted MR image of the hip joints in a 7-
year-old male child with JIA showing bilateral joint effusion, more
on the left side (straight arrows). Note signs of right sacroilitis in
the form of periarticular bone oedema (curved arrow) in this
patient.
Table 4 Logistic regression correlating MRI scores with
clinical and laboratory variables.
MRI score
R P
Age 0.01 <0.2
Disease duration 0.04 <0.1
Clinical hip score 0.1 <0.1
VAS–PGA 0.4 <0.02\
VAS-global 0.1 <0.2
ESR 0.3 <0.05\
CRP 0.07 <0.1
DAS 28 score 0.02 0.9
VAS–PGA= visual analogue scale–physician global assessment,
VAS Global = visual analogue scale, ESR= erythrocyte sedi-
mentation rate, CRP= C-reactive protein, DAS28 = disease
activity score 28.
Figure 4 Coronal T2 weighted MR image of the hip joints in a
13-year-old male child with advanced JIA showing bilateral joint
damage. Bony erosions, cartilage loss, bone remodeling and
acetabular protrusion are evident.
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the damage indices, bone erosions were found in 11% vs.
4.8%, cartilage loss in 27.8% vs. 4.8%, bone remodeling and
acetabular protrusion in 5.6% vs. none. Table 3, Figs. 1–4
illustrate various MR ﬁndings.Patients with active disease showed higher MR score
(3.7 ± 1.5) than those with inactive disease (2.1 ± 0.9)
[p< 0.002].
3.3. Factors affecting MRI score
By applying multiple logistic regression analysis, VAS–PGA
and ESR were signiﬁcantly correlated with MRI scores
(p< 0.02 and <0.05 respectively). Age, disease duration,
and DAS28 score were not signiﬁcantly correlated with MRI
scores. Table 4.
4. Discussion
Juvenile idiopathic arthritis (JIA) is one of the most common
inﬂammatory diseases of childhood and is a major cause of
disability [27]. It represents a group of heterogeneous diseases
characterized by a chronic inﬂammatory process primarily tar-
geting the synovial membrane. A persistent synovitis is associ-
ated with an increased risk of osteo-cartilagineous damage and
physical functional disability [28]. Modern therapeutic strate-
gies are aimed at an early control of inﬂammatory process in
order to prevent joint damage. As novel and highly effective
treatments are now available for treating JIA [29–31], demand
has been created for new imaging techniques that are able to
provide objective and accurate measures for the detection of
joint inﬂammatory changes and for monitoring treatment re-
sponse. Conventional radiography is quite insensitive in
depicting soft tissue changes, including synovitis, as well as
in detecting the earliest stages of erosive changes. One distinct
advantage of MRI over plain radiography is its ability to im-
age soft tissues, as well as early bony changes [32]. The use
of newer techniques and parameters of dynamic contrast
enhancement has enabled MRI to allow direct visualization
and measurement of the inﬂamed synovial membrane [16]
and to assess the microvascular blood ﬂow, volume, and cap-
illary permeability of the perisynovial tissues which are sup-
posed to closely mirror the degree of inﬂammatory activity
[17,18], as well as the proteoglycan concentration [33–35] and
degree of collagen organization of the articular cartilage
[36,37] in inﬂammatory arthropathies.
There is strength of evidence that MRI is an accurate diag-
nostic method for evaluating synovium and cartilage and for
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joints in JIA [38]. Since the hip is not a superﬁcial joint, the
clinical evaluation of active inﬂammation is difﬁcult and imag-
ing is often mandatory [39].
Few studies examined the role of MRI in evaluation of hip
disease in JIA [26,32,40,41].
In our study we tried to detect MRI ﬁndings of hip joint
involvement in a group of JIA and correlate these ﬁndings with
clinical and laboratory data. We revealed differences in the de-
gree of MRI changes in the clinical subtypes of JIA (p< 0.001
by ANOVA). Polyarthritis subset showed signiﬁcantly higher
MRI score than oligoarthritis group. This is inconsistent with
the results of Nistala et al. [26], who found that MRI scores
was not correlated with disease subtype. However patients
with systemic JIA had the highest mean scores, consistent with
the results of Argyropoulou et al. [40], who reported differ-
ences in the degree of inﬂammatory pannus and joint involve-
ment in the clinical subtypes of the disease. They found
systemic arthritis to have more severe joint disease, followed
by polyarthritis, while oligoarthritis was associated with lower
MR scores. In a previous study, Murray et al. [41] did not ﬁnd
signiﬁcant differences in the presence of pannus among the
clinical subtypes of JIA. This is probably because of the small
number of cases included in their study.
Our ﬁndings of higher frequency of MRI ﬁndings denoting
hip joint affection in polyarthritis are consistent with the re-
sults of other studies who reported a high frequency of hip
joint involvement in JIA [9,42–45].
When we compared clinically active hips with inactive ones
as regard the MRI score, active hips had higher MRI score
(p< 0.002), more joint effusion (p< 0.01) and more synovial
gadolinium enhancement (p< 0.001). This is in agreement
with the results of Argyropoulou et al. [40] who found patients
with active disease showing higher MR grades. Kirkhus et al.
[46] in their study on MRI ﬁndings in recent onset childhood
arthritis including JIA, found non-enhancing, low signal inten-
sity synovial tissue and irregular thickness of the synovium to
be more frequent in JIA than infectious arthritis.
In study of rheumatoid hands using MRI, Sugimoto et al.
[47], demonstrated that the volume of enhancing active pannus
alters in the direction indicated by changes in physical and lab-
oratory parameters of general disease activity.
As we are trying to correlate clinical ﬁndings with MRI
changes, we did not ﬁnd signiﬁcant positive correlation be-
tween clinical hip score and MRI score. Our ﬁndings of inﬂam-
mation on hip MRI in the absence of clinical signs reﬂect the
high sensitivity of MRI compared to the clinical assessment
of a deep joint like the hip, in detection of joint disease. This
is consistent with the results of Nistala et al. [26] who stated
a limited relationship between clinician’s assessment and
MRI activity score. This is also consistent with results from
a previous study of MRI of knee arthritis in children [48].
However, it is difﬁcult to make treatment recommendations
on MR ﬁndings alone as the long-term signiﬁcance of these
abnormalities is still unclear. Similar difﬁculties are faced in
the MRI of sacroilitis in ankylosing spondylitis (AS) [49]. In
AS, there is evidence that juxta-articular bony inﬂammation
can be suppressed with anti-TNF agents [50] and prospective
studies are underway to see if this favorably inﬂuences long-
term outcome.
In our study, age and disease duration were not signiﬁcantly
correlated with total MRI score. This could be explained asMRI ﬁndings of activity like joint effusion or enhancing syno-
vium may occur early in the course of the disease raising the to-
tal MRI score but may not correlate with a relatively short
disease duration (mean ± SD= 6.5 ± 3.5 years). Kirkhus
et al. [46] did not ﬁnd a relation between symptoms, duration
andMR ﬁndings in the group of JIA in their study ofMRI ﬁnd-
ings in childhood arthritis.
We’ve found that ESR and VAS–PGA are signiﬁcantly cor-
related with MRI ﬁndings. Nistala et al. [26], found that ESR
is the only core outcome variable to have such correlation and
is predictive of active hip arthritis on MRI. They stated that a
highly elevated ESR is speciﬁc for hip inﬂammation, but a nor-
mal ESR does not exclude hip arthritis on MRI.
However we found that DAS-28 as a clinical marker of dis-
ease activity, having no correlation with MR ﬁndings, this may
be explained by the fact that DAS-28 does not involve the hip
examination in calculation.
Our study did not include a healthy control group.
Although normative data on pediatric hip MRI is available
[51,52], formal validation of a scoring system will require con-
trol subjects to ensure that MRI abnormalities are not being
over-called.
In conclusion, our results highlight the role of MRI of the
hip in the study of patients with JIA as it reveals early joint
involvement and evaluates in detail the extent of joint disease.
This permits intervention at an appropriate time with suitable
treatment. Clinical and laboratory assessment of active hip
arthritis has a limited relation with MRI ﬁndings of inﬂamma-
tion. ESR and VAS–PGA are predictors of MRI results. How-
ever, MRI may be limited by cost and the need for sedation in
children, comparisons between MRI and more sensitive ultra-
sound techniques such as power Doppler would be important.References
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